Family Planning Guidelines 2020: Hormonal Contraceptives Review
Explore the latest updates on hormonal contraceptives in the National Department of Health's Family Planning Guidelines 2020. Learn about the safety, efficacy, and changes in low-dose LNG-IUS, DMPA, vaginal ring, and transdermal patch. Find out the reasons for not adding certain contraceptives due to affordability and safety concerns.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Chapter 7: Family planning NATIONAL DEPARTMENT OF HEALTH AFFORDABLE MEDICINES ESSENTIAL MEDICINES PROGRAMME PRIMARY HEALTHCARE GUIDELINES 2020 1
EVIDENCE Please access the National Essential Medicines List Committee (NEMLC) report for detailed evidence (including rationale, references and costings) informing decision-making on medicine addition, amendments and deletions: http://www.health.gov.za/index.php/standard-treatment-guidelines-and- essential-medicines-list/category/285-phc DISCLAIMER This slide set is an implementation tool and should be used alongside the most recently published STG available on the EML Clinical Guide Application. This information does not supersede or replace the STG itself. 2
Hormonal contraceptives DESCRIPTION The appropriate choice of family planning method should be decided on by the woman in consultation with the health care professional taking into consideration acceptability & access. Additional hormonal contraceptives were reviewed. safety, efficacy, CHANGES Low dose LNG-IUS Low-dose DMPA Vaginal contraceptive ring Transdermal contraceptive patch ALL NOT ADDED REASON Affordability concerns with low dose LNG-IUS, vaginal contraceptive ring and low-dose DMPA Safety concerns with the transdermal contraceptive patch 3
